Network origin in Kristin Gustafson first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Biotechnology | 36 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kristin Gustafson via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Compliance Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Human Resources Officer Director of Finance/CFO Corporate Officer/Principal | |
Biothera, Inc.
 Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Chairman Director/Board Member | |
| IPSEN | Pharmaceuticals: Major | Chief Executive Officer | |
| ANAPTYSBIO, INC. | Biotechnology | Chairman Chief Executive Officer | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Nottingham | College/University | Undergraduate Degree Undergraduate Degree | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| DMK PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Chairman | |
Ipsen Manufacturing Ireland Ltd.
 Ipsen Manufacturing Ireland Ltd. BiotechnologyHealth Technology Ipsen Manufacturing Ireland Ltd. operates as a biopharmaceutical group dedicated to improving lives through innovative medicines. The company was founded in 1989 and is headquartered in Dublin, Ireland. | Biotechnology | Chief Executive Officer | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member President | |
| UNIQURE N.V. | Biotechnology | Chairman | |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member Director/Board Member | |
| Washington University School of Medicine | College/University | Doctorate Degree | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact Corporate Officer/Principal | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chairman | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ODONATE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Chairman | |
Oncomyx Therapeutics, Inc.
 Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Oncomyx Therapeutics, Inc. develops and operates software platform to orchestrate an immune response and treat cancer. Its platform's features include non-human pathogen, immuno-stimulatory, ability to multi-arm, and systemic delivery. The company was founded by Steve Potts, Michael Wood, Grant McFadden and is headquartered in Phoenix, AZ. | Packaged Software | Chairman | |
| ACRIVON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. Packaged SoftwareTechnology Services Odyssey Therapeutics, Inc. is a biotechnology company that specializes in discovering, developing, and commercializing immunomodulators and oncology medicines. The company is based in Medfield, MA and has subsidiaries in the United Kingdom. The company is composed of a team of drug hunters, scientists, and industry leaders in foundational biology, chemistry, and data sciences. Odyssey Therapeutics aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Odyssey Therapeutics was founded by David L. Pompliano, Gary D. Glick, and Melissa Merrick, with Gary D. Glick serving as the CEO since incorporation. | Packaged Software | Director/Board Member | |
| ELEVATION ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member President Corporate Officer/Principal Director/Board Member Director/Board Member | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Camping & Education Foundation | Director/Board Member | ||
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 42 |
| Ireland | 3 |
| France | 3 |
| United Kingdom | 3 |
| Belgium | 2 |
Sectoral
| Health Technology | 40 |
| Commercial Services | 4 |
| Consumer Services | 4 |
| Technology Services | 3 |
| Finance | 3 |
Operational
| Director/Board Member | 171 |
| Independent Dir/Board Member | 77 |
| Corporate Officer/Principal | 62 |
| Chairman | 45 |
| Chief Executive Officer | 37 |
Most connected contacts
| Insiders | |
|---|---|
| Carol Gallagher | 39 |
| Michael Grey | 32 |
| Julie Cherrington | 32 |
| Faheem Hasnain | 27 |
| Bruce Carter | 25 |
| David Meek | 19 |
| Aaron Davis | 19 |
| Craig Johnson | 17 |
| Shalini Sharp | 17 |
| Chris LeMasters | 15 |
| Laurie Stelzer | 13 |
| Joseph Leveque | 12 |
| Charles Baum | 12 |
| Michael Paolucci | 10 |
| Henry Fuchs | 9 |
- Stock Market
- Insiders
- Kristin Gustafson
- Company connections
